Grace Therapeutics, Inc.
GRCE • XNAS
Grace Therapeutics, Inc. is a pharmaceutical preparations company trading on XNAS, led by CEO Prashant Kohli, with a market cap of $72.3M.
CEOPrashant Kohli
Next Earnings
Upcoming earnings announcement for Grace Therapeutics, Inc.
Date
Monday, June 22, 2026 (in 2 months)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q4 2026
EPS Estimate
-$0.24
Earnings History
Past 6 earnings reports for Grace Therapeutics, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | Q3 2026 | -$0.14Est: -$0.27 | +48.1% | - | — |  10-Q |
| Nov 13, 2025 | Q2 2026 | -$0.06Est: -$0.25 | +76.0% | - | — | 10-Q/A |
| Aug 12, 2025 | Q1 2026 | -$0.21Est: -$0.31 | +32.3% | - | — | 10-Q |
| Jun 23, 2025 | Q4 2025 | $0.10Est: -$0.29 | +134.5% | - | — | 10-K |
| Feb 13, 2025 | Q3 2025 | -$0.36Est: -$0.34 | -5.9% | - | — | 10-Q/A |
| Nov 13, 2024 | Q2 2025 | -$0.30 | — | - | — | 10-Q |